A combined CT urography and urinary cytology surveillance strategy in patients managed with endoscopic kidney-sparing surgery for upper tract urothelial carcinoma would have avoided more than two ...

Cystoscopy is the standard-of-care for evaluating patients with gross hematuria (GH), the primary sign of urothelial cancer (UC). To investigate whether Oncuria-Detect can improve detection of UC ...

New technology designed to provide a single irrigation management system for ureteroscopy, cystoscopy, percutaneous nephrolithotomy (PCNL) and benign prostatic hyperplasia (BPH) procedures. Boston ...

Cancer Res (2026) 86 (7_Supplement): 6513. Cystoscopy is standard of care in evaluating patients with gross hematuria for bladder cancer with hematuria being the primary sign of bladder cancer.

A multicentre study evaluating clinical outcomes and complications related to ureteroscopy (URS) in patients aged 80 years or older with stone disease found a 70% stone-free rate (SFR) for zero ...

NEW YORK, Sept. 12, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the cystoscopy and ureteroscopy market is observing significant growth owing to the ...

Stent omission after ureteroscopy for a small uncomplicated renal stone appears safe and preferable for patients. Stent omission after ureteroscopy, even with the use of a ureteral access sheath, may ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

Role of circulating tumor DNA (ctDNA) in locally advanced (LA) and metastatic urothelial cancer (mUC). Clinical features of patients with malignant lesions detected by BLC only (A) and those with risk ...